UGP2 and in situ carcinoma: As these biochemical markers were found stable over the years, it is suggested that two regulatory enzymes, UGPase and VAcInv, can be used as stable prognostic biochemical markers for CIS resistance for precise selection of parents to achieve a higher percentages of clones with improved CIS resistance and to screen large number of clones in a breeding program.